Skip to Main Content

Paper Details

Mitotic Dysregulation at Tumor Initiation Creates a Therapeutic Vulnerability to Combination Anti-Mitotic and Pro-Apoptotic Agents for MYCN-Driven Neuroblastoma.
Int J Mol Sci
0
2023
Author NameAffiliation
Michelle HaberChildren's Cancer Institute Australia, Lowy Cancer Research Centre, University of New South Wales
Glenn M MarshallChildren's Cancer Institute Australia, Lowy Cancer Research Centre, University of New South Wales
Glenn M MarshallUniversity of New South Wales
Glenn M MarshallKids Cancer Centre, Sydney Children's Hospital
  • 1 - 4

Datasets

Release 1.2